Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

243
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
243
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

486
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
486
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

531
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
531
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

327
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
327
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

328
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
328
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

561
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
561

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term follow up in a case of successfully treated idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN).

The British journal of ophthalmology·2004
Same author

Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2001
Same author

Comparative study of experimental choroidal neovascularization by optical coherence tomography and histopathology.

Japanese journal of ophthalmology·2001
Same author

Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.

The British journal of ophthalmology·2000
Same author

The second eye of Japanese patients with unilateral exudative age related macular degeneration.

The British journal of ophthalmology·2000
Same author

Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy.

Ophthalmic surgery and lasers·2000
Same journal

Guidance of Medical Care for Familial Exudative Vitreoretinopathy：Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants.

Nippon Ganka Gakkai zasshi·2018
Same journal

Steroid Resistant Vogt-Koyanagi-Harada Disease Treated Effectively with Cyclosporine.

Nippon Ganka Gakkai zasshi·2018
Same journal

The Effect of Low-dose Cyclosporine (100 mg Once Daily) for Chronic Vogt-Koyanagi-Harada Disease.

Nippon Ganka Gakkai zasshi·2018
Same journal

Clinical Classification of Degree of Deficiency in Color Defectiveness: Simulations by Changing the Total Number of Caps or Saturation of Farnsworth Dichotomous Test D-15.

Nippon Ganka Gakkai zasshi·2018
Same journal

Accelerated Epithelial Proliferation in a Rabbit Model of Bullous Keratopathy.

Nippon Ganka Gakkai zasshi·2018
Same journal

Non-infectious Uveitis and Immunosuppressants：Where We Stand and What the Future Holds.

Nippon Ganka Gakkai zasshi·2018
See all related articles

Related Experiment Video

Updated: Jan 26, 2026

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

6.3K

[Choroidal neovascularization, experimental and clinical study].

M Uyama1

  • 1Department of Ophthalmology, Kansai Medical University.

Nippon Ganka Gakkai Zasshi
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Experimental studies reveal the retinal pigment epithelium (RPE) influences choroidal neovascularization (ChNV). Clinical data on exudative age-related macular degeneration highlights RPE degeneration and drusen as predisposing factors for vision loss.

More Related Videos

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
09:56

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

9.9K
A Mouse Model for Laser-induced Choroidal Neovascularization
07:08

A Mouse Model for Laser-induced Choroidal Neovascularization

Published on: December 27, 2015

18.8K

Related Experiment Videos

Last Updated: Jan 26, 2026

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

6.3K
In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
09:56

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

9.9K
A Mouse Model for Laser-induced Choroidal Neovascularization
07:08

A Mouse Model for Laser-induced Choroidal Neovascularization

Published on: December 27, 2015

18.8K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Macular Degeneration

Context:

  • Choroidal neovascularization (ChNV) is a key factor in exudative age-related macular degeneration (AMD).
  • The Japanese Ophthalmological Society's 95th annual Congress featured research on ChNV and AMD.
  • AMD is a leading cause of blindness in Japan's elderly population.

Purpose:

  • To present experimental findings on choroidal neovascularization (ChNV) in monkey eyes.
  • To analyze clinical features, predisposing signs, and outcomes of senile disciform macular degeneration (exudative AMD).
  • To emphasize the importance of early detection and laser treatment for preventing blindness.

Summary:

  • Experimental ChNV was induced in monkey eyes using krypton laser photocoagulation, demonstrating the retinal pigment epithelium's (RPE) role in ChNV development and involution.
  • A 5-year study of 473 eyes with exudative AMD identified RPE degeneration, drusen, and serous RPE detachment as predisposing factors.
  • Outcomes varied by disease form: early serous retinal detachment responded well to laser treatment, while advanced forms and subretinal cystic forms had poorer prognoses.

Impact:

  • Findings underscore the critical role of the retinal pigment epithelium in the pathogenesis of ChNV.
  • The study provides a detailed classification of exudative AMD forms and their associated prognoses.
  • Early diagnosis and timely laser intervention are crucial for mitigating vision loss from exudative AMD.